Scherle Peggy

Track

Insider profile

Scherle Peggy's trades of Prelude Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-05-11 2021-05-07
PlS Planned sale
98,756 +20.1%
309.35
US$3,502,213 		98,756 +20.1% 309.35 US$3,502,213
2021-05-11 2021-05-07
PlS Planned sale
90,011 +46.5%
287.64
US$1,390,836 		90,011 +46.5% 287.64 US$1,390,836
2021-05-11 2021-05-07
PlS Planned sale
87,660 +29.6%
159.29
US$1,672,645 		87,660 +29.6% 159.29 US$1,672,645
2021-04-15 2021-04-08
PlS Planned sale
1,669 -1.0%
39.57
US$66,040 		1,669 -1.0% 39.57 US$66,040
2021-04-15 2021-04-08
PlS Planned sale
669 -0.4%
38.97
US$26,073 		669 -0.4% 38.97 US$26,073
2021-04-15 2021-04-08
PlS Planned sale
875 -0.5%
37.72
US$33,003 		875 -0.5% 37.72 US$33,003
2021-04-15 2021-04-08
PlS Planned sale
1,417 -0.8%
36.97
US$52,387 		1,417 -0.8% 36.97 US$52,387
2021-04-09 2021-04-07
PlS Planned sale
200 -0.1%
40.30
US$8,060 		200 -0.1% 40.30 US$8,060
2021-04-09 2021-04-07
PlS Planned sale
6,881 -3.8%
39.63
US$272,679 		6,881 -3.8% 39.63 US$272,679
2021-04-09 2021-04-07
PlS Planned sale
8,289 -4.4%
39.02
US$323,405 		8,289 -4.4% 39.02 US$323,405